Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1446642

Hannover Medical School - Product Pipeline Review - Q4 2010

Description:
Hannover Medical School – Product Pipeline Review – Q4 2010

Summary

Global Market Direct’s pharmaceuticals report, “Hannover Medical School – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable).

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together by Global Markets Direct’s team of industry experts.

Scope

- Review of therapeutics under development by Hannover Medical School.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Hannover Medical School with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of Hannover Medical School’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.

Reasons to buy

- Identify new drug targets and therapeutic classes in Hannover Medical School’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate Hannover Medical School’s position with total access to a detailed information on its therapeutic products development.
- Assess the growth potential of Hannover Medical School in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with Hannover Medical School.
- Avoid Intellectual Property Rights related issues.
 
Contents:

List of Tables
List of Figures
Hannover Medical School Snapshot
Key Information
Key Facts
Hannover Medical School – Research and Development Overview
Key Therapeutic Areas
Hannover Medical School – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Hannover Medical School – Pipeline Products Glance
Hannover Medical School – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Hannover Medical School Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Hannover Medical School – Drug Profiles
Advagraf
Product Description
Mechanism of Action
R&D Progress
Cyclophosphamide
Product Description
Mechanism of Action
R&D Progress
Cyclophosphamide
Product Description
Mechanism of Action
R&D Progress
cytarabine + daunorubicin
Product Description
Mechanism of Action
R&D Progress
Cytarabine+ Idarubicin +Etoposide+ Fludarabine +G-CSF
Product Description
Mechanism of Action
R&D Progress
Enoxaparin
Product Description
Mechanism of Action
R&D Progress
Enoxaparin + Taxotere
Product Description
Mechanism of Action
R&D Progress
Everolimus
Product Description
Mechanism of Action
R&D Progress
Moxifloxacin + Metronidazole
Product Description
Mechanism of Action
R&D Progress
Prograf
Product Description
Mechanism of Action
R&D Progress
Recombinant Erythropoietin Alpha
Product Description
Mechanism of Action
R&D Progress
Rituximab
Product Description
Mechanism of Action
R&D Progress
Bromocriptine
Product Description
Mechanism of Action
R&D Progress
filgrastim + asparaginase + cytarabine + daunorubicin hydrochloride + dexamethasone + etoposide + idarubicin + ifosfamide + leucovorin calcium + methotrexate + prednisolone + vindesine
Product Description
Mechanism of Action
R&D Progress
filgrastim + asparaginase + cytarabine + daunorubicin hydrochloride + dexamethasone + etoposide + idarubicin + ifosfamide + leucovorin calcium + methotrexate + prednisolone + vindesine
Product Description
Mechanism of Action
R&D Progress
ivabradine
Product Description
Mechanism of Action
R&D Progress
mHag HA1/ HA2 Peptides Vaccine
Product Description
Mechanism of Action
R&D Progress
Temsirolimus
Product Description
Mechanism of Action
R&D Progress
Hannover Medical School – Pipeline Analysis
Hannover Medical School – Pipeline Products by Therapeutic Class
Hannover Medical School Pipeline Products By Target
Hannover Medical School – Pipeline Products by Route of Administration
Hannover Medical School – Pipeline Products by Molecule Type
Hannover Medical School - Dormant Projects
Hannover Medical School – Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1446642

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Sep 30th 2014
4:38:58 PM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Hannover Medical School - Product Pipeline Review - Q4 2010

Web Address

http://www.researchandmarkets.com/reports/1446642

Office Code

OCGOOGLE

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User USD 500
Electronic (PDF) - Site License USD 1,000
Electronic (PDF) - Enterprisewide USD 1,500

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Sep 30th 2014
4:38:58 PM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)